Technology | February 11, 2013

New Competitor Enters IVUS Market

Silicon Valley Medical Instruments Inc.  HD-IVUS FDA Clearance

February 11, 2013 — Silicon Valley Medical Instruments Inc. (SVMI) was granted 510(k) market clearance from the U.S. Food and Drug Administration (FDA) in January for its HD-IVUS ultrasound imaging system.

The HD-IVUS ultrasound imaging system is a minimally invasive intravascular ultrasound diagnostic imaging tool, used in conjunction with an intravascular ultrasound catheter. The system is a medical device for use by or on the order of a physician. The HD-IVUS is comprised of a system console with a touchscreen monitor, roll stand or bed-rail swing arm mount, patient interface module (PIM), power supply, and an intravascular ultrasound catheter [510(k)-cleared and  sold separately].

The catheter emits sound energy from a transducer at the distal tip of the catheter, which is guided into the coronary arteries of the heart. Sound waves that reflect from the inner vascular tissues are received by the transducer and sent to the system console where a high-resolution, cross-sectional image is displayed in real time. The technique provides for in vivo visualization of the coronary artery lumen, coronary artery wall morphology, and devices (such as stents) at or near the surface of the coronary artery wall.

The system console receives, processes, displays and records ultrasound image data from the transducer in the Kodama HD-IVUS catheter. The IVUS images are displayed on a high-resolution, 19-inch, flat-panel, touchscreen monitor. The monitor serves as a graphical user interface (GUI) for operating the system. All system information and controls are located on the touchscreen monitor.

The HD-IVUS system also has internal storage for patient studies. Each study can contain data in the form of loops or stills. Study data is saved in digital imaging and communications in medicine (DICOM) format and can be exported to DVID, using the integrated DVD drive, or to a USIB storage device, using one of the four USB ports.

For more information:

Related Content

Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.